Determinants of Response to Talazoparib in Patients with HER2-Negative, Germline BRCA1/2-Mutated Breast Cancer

  1. Blum, J.L.
  2. Douglas Laird, A.
  3. Litton, J.K.
  4. Rugo, H.S.
  5. Ettl, J.
  6. Hurvitz, S.A.
  7. Martin, M.
  8. Roché, H.H.
  9. Lee, K.-H.
  10. Goodwin, A.
  11. Chen, Y.
  12. Lanzalone, S.
  13. Chelliserry, J.
  14. Czibere, A.
  15. Hopkins, J.F.
  16. Albacker, L.A.
  17. Mina, L.A.
Revue:
Clinical Cancer Research

ISSN: 1557-3265,  1078-0432

Année de publication: 2022

Volumen: 28

Número: 7

Pages: 1383-1390

Type: Article

DOI: 10.1158/1078-0432.CCR-21-2080 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus